 Dylan Taatjes
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 35 | 2025 | 324 | 11.370 |
Why?
| | Mediator Complex | 27 | 2025 | 61 | 9.270 |
Why?
| | Transcription, Genetic | 42 | 2025 | 1457 | 7.510 |
Why?
| | Cyclin-Dependent Kinases | 15 | 2025 | 132 | 6.840 |
Why?
| | Transcription Factors | 29 | 2025 | 1719 | 3.870 |
Why?
| | Cyclin-Dependent Kinase 8 | 13 | 2025 | 43 | 3.430 |
Why?
| | Transcription Factor TFIIH | 9 | 2025 | 37 | 3.280 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2022 | 528 | 2.650 |
Why?
| | Promoter Regions, Genetic | 14 | 2025 | 1250 | 2.380 |
Why?
| | Gene Expression Regulation | 22 | 2025 | 2607 | 2.370 |
Why?
| | Transcription Initiation, Genetic | 6 | 2025 | 15 | 2.070 |
Why?
| | Transcription Factor TFIID | 3 | 2021 | 21 | 1.380 |
Why?
| | Transcriptional Activation | 8 | 2025 | 378 | 1.200 |
Why?
| | Multiprotein Complexes | 5 | 2017 | 163 | 1.170 |
Why?
| | Chromatin | 12 | 2022 | 519 | 1.130 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 305 | 0.970 |
Why?
| | Transcription Initiation Site | 4 | 2021 | 43 | 0.940 |
Why?
| | Protein Binding | 19 | 2024 | 2224 | 0.880 |
Why?
| | Antibiotics, Antineoplastic | 7 | 2001 | 127 | 0.870 |
Why?
| | Transcription Factors, TFII | 4 | 2015 | 41 | 0.860 |
Why?
| | Interferons | 1 | 2025 | 202 | 0.820 |
Why?
| | Cryoelectron Microscopy | 8 | 2025 | 190 | 0.800 |
Why?
| | Cell Nucleus | 7 | 2021 | 620 | 0.750 |
Why?
| | Protein Subunits | 8 | 2015 | 239 | 0.740 |
Why?
| | Saccharomyces cerevisiae | 6 | 2022 | 557 | 0.720 |
Why?
| | Doxorubicin | 8 | 2000 | 362 | 0.710 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2022 | 405 | 0.700 |
Why?
| | Trans-Activators | 6 | 2011 | 398 | 0.700 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 916 | 0.680 |
Why?
| | Humans | 73 | 2025 | 137585 | 0.680 |
Why?
| | Daunorubicin | 7 | 2000 | 26 | 0.620 |
Why?
| | Cell Proliferation | 2 | 2025 | 2475 | 0.620 |
Why?
| | Phosphorylation | 10 | 2025 | 1759 | 0.610 |
Why?
| | Drosophila | 1 | 2020 | 154 | 0.600 |
Why?
| | Signal Transduction | 8 | 2025 | 5079 | 0.600 |
Why?
| | Phosphoproteins | 2 | 2023 | 338 | 0.590 |
Why?
| | Phenanthrenes | 1 | 2018 | 13 | 0.580 |
Why?
| | Diterpenes | 1 | 2018 | 31 | 0.580 |
Why?
| | Down Syndrome | 1 | 2025 | 496 | 0.580 |
Why?
| | Drosophila Proteins | 1 | 2020 | 204 | 0.570 |
Why?
| | Molecular Biology | 1 | 2018 | 59 | 0.570 |
Why?
| | Biophysics | 1 | 2018 | 71 | 0.560 |
Why?
| | Cell Line | 9 | 2025 | 2847 | 0.550 |
Why?
| | Formaldehyde | 6 | 2000 | 63 | 0.540 |
Why?
| | Polycyclic Compounds | 2 | 2016 | 13 | 0.530 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 21 | 0.530 |
Why?
| | Osteosarcoma | 1 | 2017 | 74 | 0.520 |
Why?
| | Animals | 29 | 2025 | 36940 | 0.500 |
Why?
| | Models, Biological | 3 | 2020 | 1783 | 0.500 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2015 | 7 | 0.490 |
Why?
| | Porins | 1 | 2015 | 13 | 0.490 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2015 | 5 | 0.470 |
Why?
| | Mediator Complex Subunit 1 | 3 | 2020 | 5 | 0.470 |
Why?
| | E1A-Associated p300 Protein | 1 | 2015 | 11 | 0.470 |
Why?
| | HeLa Cells | 11 | 2019 | 636 | 0.460 |
Why?
| | RNA | 1 | 2021 | 921 | 0.450 |
Why?
| | Bone Neoplasms | 1 | 2017 | 247 | 0.450 |
Why?
| | Leiomyoma | 1 | 2015 | 77 | 0.440 |
Why?
| | Protein Kinases | 1 | 2016 | 319 | 0.430 |
Why?
| | Uterine Neoplasms | 1 | 2015 | 109 | 0.420 |
Why?
| | Estrogen Receptor alpha | 1 | 2015 | 145 | 0.420 |
Why?
| | DNA | 7 | 2022 | 1459 | 0.420 |
Why?
| | Protein Conformation | 7 | 2021 | 934 | 0.410 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 412 | 0.410 |
Why?
| | Protein Structure, Quaternary | 4 | 2021 | 128 | 0.410 |
Why?
| | Epirubicin | 4 | 2002 | 4 | 0.390 |
Why?
| | DNA Helicases | 4 | 2022 | 145 | 0.380 |
Why?
| | Antineoplastic Agents | 7 | 2020 | 2129 | 0.380 |
Why?
| | HCT116 Cells | 4 | 2021 | 80 | 0.370 |
Why?
| | Genes, p53 | 3 | 2021 | 72 | 0.360 |
Why?
| | Enzyme Activation | 3 | 2020 | 810 | 0.360 |
Why?
| | Enhancer Elements, Genetic | 5 | 2024 | 190 | 0.360 |
Why?
| | Imidazoles | 3 | 2021 | 238 | 0.330 |
Why?
| | DNA Repair | 4 | 2022 | 231 | 0.330 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 64 | 0.330 |
Why?
| | Histones | 3 | 2015 | 636 | 0.320 |
Why?
| | Mass Spectrometry | 9 | 2015 | 739 | 0.310 |
Why?
| | Tumor Cells, Cultured | 8 | 2017 | 955 | 0.310 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 1502 | 0.310 |
Why?
| | Proteomics | 1 | 2016 | 1111 | 0.310 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.310 |
Why?
| | Piperazines | 3 | 2021 | 350 | 0.300 |
Why?
| | Cell Cycle | 2 | 2025 | 601 | 0.300 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1396 | 0.300 |
Why?
| | Models, Molecular | 8 | 2015 | 1570 | 0.290 |
Why?
| | DNA Adducts | 5 | 1999 | 17 | 0.290 |
Why?
| | Serine | 3 | 2023 | 141 | 0.280 |
Why?
| | Histone Acetyltransferases | 1 | 2008 | 60 | 0.270 |
Why?
| | Nuclear Proteins | 4 | 2020 | 712 | 0.270 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 34 | 0.260 |
Why?
| | Recombinant Proteins | 6 | 2020 | 1353 | 0.260 |
Why?
| | Mitochondria | 1 | 2013 | 948 | 0.260 |
Why?
| | Repressor Proteins | 2 | 2014 | 427 | 0.260 |
Why?
| | Protein Isoforms | 2 | 2021 | 404 | 0.250 |
Why?
| | Substrate Specificity | 3 | 2023 | 372 | 0.240 |
Why?
| | Crystallography, X-Ray | 4 | 2017 | 476 | 0.230 |
Why?
| | Proteome | 2 | 2023 | 472 | 0.230 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 430 | 0.230 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 200 | 0.230 |
Why?
| | Genes, Regulator | 1 | 2004 | 37 | 0.220 |
Why?
| | Protein Structure, Tertiary | 6 | 2013 | 861 | 0.220 |
Why?
| | Receptors, Calcitriol | 1 | 2004 | 55 | 0.220 |
Why?
| | Interferon-gamma | 2 | 2019 | 789 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2020 | 801 | 0.200 |
Why?
| | Aging | 1 | 2013 | 1864 | 0.200 |
Why?
| | Threonine | 1 | 2023 | 47 | 0.200 |
Why?
| | Escherichia coli | 2 | 2017 | 815 | 0.190 |
Why?
| | Yeasts | 1 | 2022 | 53 | 0.190 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 3 | 2010 | 6 | 0.190 |
Why?
| | Molecular Probes | 1 | 2022 | 36 | 0.190 |
Why?
| | DNA, Neoplasm | 2 | 1999 | 164 | 0.190 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 327 | 0.190 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2010 | 57 | 0.190 |
Why?
| | Nucleic Acid Conformation | 5 | 2016 | 728 | 0.170 |
Why?
| | HL-60 Cells | 1 | 2020 | 34 | 0.170 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 289 | 0.170 |
Why?
| | Mammals | 1 | 2022 | 283 | 0.170 |
Why?
| | Fluorouracil | 1 | 2021 | 208 | 0.170 |
Why?
| | Cell Survival | 2 | 2020 | 1120 | 0.160 |
Why?
| | Software | 1 | 2025 | 665 | 0.160 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 327 | 0.160 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.160 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 48 | 0.150 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2018 | 18 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 425 | 0.150 |
Why?
| | Genetic Variation | 1 | 2004 | 991 | 0.150 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2018 | 30 | 0.150 |
Why?
| | Alternative Splicing | 1 | 2020 | 229 | 0.150 |
Why?
| | Alkylating Agents | 1 | 1998 | 24 | 0.150 |
Why?
| | Anthracyclines | 1 | 1998 | 42 | 0.150 |
Why?
| | Epoxy Compounds | 1 | 2018 | 33 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2004 | 879 | 0.140 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2025 | 57 | 0.140 |
Why?
| | Fibroblasts | 3 | 2019 | 996 | 0.140 |
Why?
| | RNA Splicing | 1 | 2019 | 269 | 0.140 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 18 | 0.140 |
Why?
| | STAT1 Transcription Factor | 2 | 2019 | 72 | 0.140 |
Why?
| | Mutation | 3 | 2021 | 3958 | 0.130 |
Why?
| | Biology | 1 | 2018 | 88 | 0.130 |
Why?
| | Drug Design | 1 | 1998 | 167 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2020 | 617 | 0.130 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2017 | 44 | 0.130 |
Why?
| | Research | 1 | 2020 | 451 | 0.130 |
Why?
| | HEK293 Cells | 5 | 2019 | 730 | 0.130 |
Why?
| | DNA Damage | 1 | 2019 | 420 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 938 | 0.120 |
Why?
| | Peptides | 1 | 2022 | 985 | 0.120 |
Why?
| | Mitosis | 1 | 2017 | 192 | 0.120 |
Why?
| | RNA, Bacterial | 1 | 2017 | 190 | 0.120 |
Why?
| | Genes, Neoplasm | 1 | 2015 | 22 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 436 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 434 | 0.120 |
Why?
| | Glutathione | 2 | 2013 | 356 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2017 | 337 | 0.120 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 136 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2020 | 126 | 0.120 |
Why?
| | Neoplasms | 2 | 2020 | 2671 | 0.120 |
Why?
| | Cholesterol | 1 | 2017 | 410 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.120 |
Why?
| | Alkylation | 4 | 1999 | 26 | 0.120 |
Why?
| | Quinine | 1 | 2014 | 20 | 0.110 |
Why?
| | Antimalarials | 1 | 2014 | 31 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 840 | 0.110 |
Why?
| | Antigen-Antibody Complex | 1 | 2014 | 90 | 0.110 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 328 | 0.110 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2014 | 73 | 0.110 |
Why?
| | Models, Genetic | 2 | 2011 | 600 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2015 | 150 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 72 | 0.100 |
Why?
| | RNA, Untranslated | 1 | 2015 | 124 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2013 | 59 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 37 | 0.100 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 15 | 0.100 |
Why?
| | RNA-Binding Protein FUS | 1 | 2012 | 13 | 0.100 |
Why?
| | Epigenomics | 1 | 2013 | 115 | 0.100 |
Why?
| | Macromolecular Substances | 2 | 2004 | 229 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2013 | 2900 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 1997 | 597 | 0.090 |
Why?
| | Cell Line, Tumor | 5 | 2024 | 3412 | 0.090 |
Why?
| | Pyrococcus furiosus | 1 | 2010 | 3 | 0.090 |
Why?
| | Protein Biosynthesis | 1 | 2013 | 433 | 0.090 |
Why?
| | Protein Multimerization | 1 | 2012 | 192 | 0.090 |
Why?
| | Transcription Factor TFIIB | 1 | 2010 | 13 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 181 | 0.080 |
Why?
| | Archaeal Proteins | 1 | 2010 | 50 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2139 | 0.080 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 213 | 0.080 |
Why?
| | DNA, Single-Stranded | 1 | 2011 | 118 | 0.080 |
Why?
| | Biochemistry | 1 | 2010 | 38 | 0.080 |
Why?
| | Serum Response Factor | 1 | 2010 | 33 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 1998 | 1060 | 0.080 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2010 | 104 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2011 | 122 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2010 | 129 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 375 | 0.080 |
Why?
| | DNA Polymerase II | 1 | 2009 | 37 | 0.080 |
Why?
| | Coenzymes | 1 | 2008 | 19 | 0.080 |
Why?
| | Pol1 Transcription Initiation Complex Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 630 | 0.070 |
Why?
| | Cell Lineage | 2 | 2024 | 350 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2016 | 2833 | 0.070 |
Why?
| | Cyclins | 1 | 2008 | 91 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1502 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1092 | 0.070 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 433 | 0.070 |
Why?
| | Telomere | 1 | 2011 | 280 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3284 | 0.070 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 138 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 465 | 0.070 |
Why?
| | Dithiothreitol | 2 | 1997 | 17 | 0.070 |
Why?
| | Protein Domains | 2 | 2019 | 289 | 0.070 |
Why?
| | Acetylation | 1 | 2008 | 248 | 0.070 |
Why?
| | Vesiculovirus | 2 | 2019 | 16 | 0.060 |
Why?
| | Mice | 7 | 2019 | 17787 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3295 | 0.060 |
Why?
| | Microscopy, Electron | 3 | 2002 | 443 | 0.060 |
Why?
| | Hydrogen Peroxide | 2 | 1997 | 328 | 0.060 |
Why?
| | Molecular Structure | 2 | 2014 | 489 | 0.060 |
Why?
| | Cell Division | 2 | 2015 | 794 | 0.060 |
Why?
| | STAT3 Transcription Factor | 2 | 2019 | 206 | 0.060 |
Why?
| | Vitamin D Response Element | 1 | 2004 | 1 | 0.060 |
Why?
| | Sp1 Transcription Factor | 1 | 2004 | 24 | 0.060 |
Why?
| | Hydrolysis | 3 | 2002 | 177 | 0.050 |
Why?
| | Kinetics | 2 | 2016 | 1670 | 0.050 |
Why?
| | Binding Sites | 2 | 2004 | 1303 | 0.050 |
Why?
| | Phosphothreonine | 1 | 2023 | 6 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1774 | 0.050 |
Why?
| | Phosphoserine | 1 | 2023 | 34 | 0.050 |
Why?
| | Species Specificity | 1 | 2004 | 585 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2023 | 121 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2002 | 665 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2002 | 100 | 0.050 |
Why?
| | TATA-Box Binding Protein | 2 | 2013 | 20 | 0.050 |
Why?
| | Cross-Linking Reagents | 3 | 2015 | 217 | 0.050 |
Why?
| | Mutagenesis | 1 | 2022 | 179 | 0.050 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2002 | 68 | 0.050 |
Why?
| | Base Sequence | 2 | 2016 | 2181 | 0.040 |
Why?
| | Genetic Techniques | 1 | 2021 | 64 | 0.040 |
Why?
| | Oligonucleotides | 2 | 1999 | 148 | 0.040 |
Why?
| | Breast | 1 | 2021 | 151 | 0.040 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2020 | 22 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2004 | 493 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 168 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2019 | 5 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2019 | 43 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2021 | 155 | 0.040 |
Why?
| | STAT Transcription Factors | 1 | 2019 | 17 | 0.040 |
Why?
| | Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 13 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 1999 | 82 | 0.040 |
Why?
| | Immunoglobulin G | 2 | 2014 | 893 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 53 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2019 | 80 | 0.040 |
Why?
| | Dexamethasone | 1 | 2021 | 368 | 0.040 |
Why?
| | Models, Chemical | 2 | 1997 | 263 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 168 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 390 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 491 | 0.040 |
Why?
| | Chemistry, Pharmaceutical | 1 | 1998 | 105 | 0.040 |
Why?
| | Drug Carriers | 1 | 1999 | 128 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 580 | 0.040 |
Why?
| | Microscopy, Atomic Force | 2 | 2014 | 126 | 0.040 |
Why?
| | Synaptic Vesicles | 1 | 1998 | 44 | 0.030 |
Why?
| | Buffers | 1 | 1997 | 56 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 175 | 0.030 |
Why?
| | Anaerobiosis | 1 | 1997 | 64 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 192 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1998 | 194 | 0.030 |
Why?
| | Oxazoles | 1 | 1997 | 37 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1997 | 106 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 752 | 0.030 |
Why?
| | Nucleic Acids | 1 | 1998 | 71 | 0.030 |
Why?
| | Xanthine Oxidase | 1 | 1997 | 81 | 0.030 |
Why?
| | beta Catenin | 1 | 2019 | 253 | 0.030 |
Why?
| | Breast Neoplasms | 2 | 2000 | 2253 | 0.030 |
Why?
| | NAD | 1 | 1997 | 77 | 0.030 |
Why?
| | Uridine Triphosphate | 1 | 2016 | 10 | 0.030 |
Why?
| | Sulfhydryl Reagents | 1 | 1996 | 12 | 0.030 |
Why?
| | Computer Simulation | 1 | 2021 | 978 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1996 | 86 | 0.030 |
Why?
| | Fluorescence | 1 | 2017 | 160 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1998 | 560 | 0.030 |
Why?
| | Guanosine Triphosphate | 1 | 2016 | 91 | 0.030 |
Why?
| | Immunologic Techniques | 2 | 2014 | 40 | 0.030 |
Why?
| | Nerve Tissue Proteins | 2 | 1998 | 596 | 0.030 |
Why?
| | Computational Biology | 1 | 2021 | 644 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 364 | 0.030 |
Why?
| | Oxidants | 1 | 1996 | 111 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2016 | 343 | 0.030 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Female | 5 | 2021 | 73304 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2015 | 8 | 0.030 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2015 | 20 | 0.030 |
Why?
| | Chromaffin Granules | 1 | 1995 | 3 | 0.030 |
Why?
| | Adrenal Medulla | 1 | 1995 | 9 | 0.030 |
Why?
| | Genes, Tumor Suppressor | 1 | 2015 | 86 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 611 | 0.030 |
Why?
| | Iron | 1 | 1997 | 313 | 0.030 |
Why?
| | Flow Cytometry | 1 | 1999 | 1178 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 409 | 0.030 |
Why?
| | beta 2-Glycoprotein I | 1 | 2014 | 6 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2021 | 1096 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2014 | 19 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 17 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 367 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 1995 | 93 | 0.030 |
Why?
| | Tripartite Motif-Containing Protein 28 | 1 | 2014 | 18 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 66 | 0.030 |
Why?
| | Cytoplasmic Granules | 1 | 1995 | 93 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1995 | 161 | 0.030 |
Why?
| | Antibodies, Antiphospholipid | 1 | 2014 | 25 | 0.030 |
Why?
| | Hydroxychloroquine | 1 | 2014 | 58 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2013 | 12 | 0.030 |
Why?
| | Muscle Hypotonia | 1 | 2013 | 33 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2013 | 67 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 657 | 0.030 |
Why?
| | Anus, Imperforate | 1 | 2013 | 24 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2013 | 57 | 0.020 |
Why?
| | Phospholipids | 1 | 2014 | 223 | 0.020 |
Why?
| | Ubiquitination | 1 | 2013 | 102 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2013 | 145 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 843 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3015 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2013 | 269 | 0.020 |
Why?
| | Proteolysis | 1 | 2013 | 177 | 0.020 |
Why?
| | Constipation | 1 | 2013 | 94 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1998 | 1164 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2011 | 86 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 767 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2010 | 17 | 0.020 |
Why?
| | Serum Response Element | 1 | 2010 | 6 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 305 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2010 | 92 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 374 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 109 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 422 | 0.020 |
Why?
| | Neurons | 1 | 1998 | 1590 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5757 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 778 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1226 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4193 | 0.020 |
Why?
| | Sialic Acids | 1 | 1985 | 10 | 0.020 |
Why?
| | Sialyltransferases | 1 | 1985 | 13 | 0.020 |
Why?
| | Transferases | 1 | 1985 | 33 | 0.020 |
Why?
| | Golgi Apparatus | 1 | 1985 | 100 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2002 | 106 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 345 | 0.010 |
Why?
| | Immunoblotting | 1 | 2002 | 308 | 0.010 |
Why?
| | Rats | 3 | 1998 | 5647 | 0.010 |
Why?
| | Male | 2 | 2015 | 67762 | 0.010 |
Why?
| | Cell Death | 1 | 2002 | 374 | 0.010 |
Why?
| | Ligands | 1 | 2002 | 664 | 0.010 |
Why?
| | Intercalating Agents | 1 | 1999 | 5 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 332 | 0.010 |
Why?
| | R-SNARE Proteins | 1 | 1998 | 19 | 0.010 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 1998 | 25 | 0.010 |
Why?
| | Qa-SNARE Proteins | 1 | 1998 | 20 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 199 | 0.010 |
Why?
| | Catalysis | 1 | 1997 | 307 | 0.010 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 1995 | 5 | 0.010 |
Why?
| | Hemagglutinins, Viral | 1 | 1995 | 7 | 0.010 |
Why?
| | PC12 Cells | 1 | 1995 | 40 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 1995 | 46 | 0.010 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1995 | 25 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1995 | 219 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1995 | 390 | 0.010 |
Why?
| | Cell Membrane | 1 | 1998 | 738 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1995 | 319 | 0.010 |
Why?
| | Transfection | 1 | 1995 | 945 | 0.010 |
Why?
| | Cattle | 1 | 1995 | 984 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1998 | 2486 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4295 | 0.010 |
Why?
| | Thiamine Pyrophosphatase | 1 | 1985 | 1 | 0.000 |
Why?
| | Nucleotidases | 1 | 1985 | 7 | 0.000 |
Why?
| | Glycoproteins | 1 | 1985 | 342 | 0.000 |
Why?
| | Liver | 1 | 1985 | 1943 | 0.000 |
Why?
|
|
Taatjes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|